Explore: Hemoglobinopathy

Hemoglobinopathy is the medical term for a group of inherited blood disorders involving the hemoglobin, the major protein of red blood cells. They are

it constitutes 96-97% of total hemoglobin in individuals without a hemoglobinopathy. It is composed of two alpha globins and two beta globins (α2β2). Hemoglobin

it constitutes 96-97% of total hemoglobin in individuals without a hemoglobinopathy. It is composed of two alpha globins and two beta globins (α2β2). Hemoglobin

combination hemoglobinopathy occurs when someone inherits two different abnormal hemoglobin genes. Alpha thalassemia can coexist with other hemoglobinopathies such

resistance. Hemoglobinopathies are a class of monogenic disorders that impact the major red blood cell protein hemoglobin. Hemoglobinopathies interfere

hematological malignancies such as lymphoma and leukemia (cancers) treating hemoglobinopathies, including α-thalassemias and β-thalassemias (thalassemia syndromes)

vessels, defects in growth and optical problems. To rehabilitate β-hemoglobinopathies, the patient's multipotent cells are transferred in a mice model to

differentiate the two. Testing a person to make sure they do not have a hemoglobinopathy may also be reasonable. Penile ultrasonography with Doppler is the

some cause a group of hereditary diseases called hemoglobinopathies. The best known hemoglobinopathy is sickle-cell disease, which was the first human

under the broad category of hemoglobinopathies. Worldwide, it is estimated that 7% of the population may carry a hemoglobinopathy with clinical significance